Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Hepatol. Aug 27, 2022; 14(8): 1584-1597
Published online Aug 27, 2022. doi: 10.4254/wjh.v14.i8.1584
Figure 1
Figure 1 Schematic for mortality outcome at 52 wk for patients requiring SBT for acute severe variceal bleeding. SBT: Sengstaken-Blakemore tube; TIPS: Transjugular intrahepatic portosystemic shunt.
Figure 2
Figure 2 Survival curve for Model for Endstage Liver disease score > 19 over 52 wk. MELD score: Model for end-stage liver disease score.
Figure 3
Figure 3 Survival curve for hepatocellular carcinoma over 52 wk. HCC: Hepatocellular carcinoma.
Figure 4
Figure 4 Survival curve for re-bleeding over 52 wk.